This year’s Respiratory Medicine Symposium encompassed a variety of clinically relevant topics with particular emphasis on current and future management strategies. Commonly encountered clinical scenarios such as the investigation of solitary pulmonary nodules, advising snorers on surgical options and optimising asthma control in both primary and secondary care as well as rarer conditions such as pulmonary arteriovenous malformations were presented. The Robert W Phillip Memorial Lecture focused on the diagnosis of PE.
Get full access to this article
View all access options for this article.
References
1.
YoungJWMcDonaldJP.An investigation into the relationship between the severity of obstructive sleep apnoea/hypopnoea syndrome and the vertical position of the hyoid bone. Surgeon 2004; 2(3):141–51.
2.
HesselNSde VriesN. Results of uvulopalatopharyngoplasty after diagnostic work up with polysomnography and sleep endoscopy: a report of 136 snoring patients. Eur Arch Otorhinolaryngol 2003; 260(2):91–5.
3.
PrasadKRKPremrajSEKentReddyKT.Surgery for snoring. Are partners satisfied in the long run? Clin Otolaryngol Allied Sci 2003; 28(6):497–502.
4.
RoosliCSSchneiderHauslerR. Long-term results and complications following uvulopalatopharyngoplasty in 116 consecutive patients. Eur Arch Otorhinolaryngol 2006; 263(8):754–8.
5.
RemyJMRemy-Jardin,Wattinne L, Deffotaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992; 182(3):809–16.
6.
Begbie ME,Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler–Weber–Rendu syndrome): a view from the 21st century. Postgrad Med J 2003; 79(927):18–24.
7.
DahlbackBMCarlssonSvenssonPJ.Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 1993; 90(3):1004–8.
8.
BertinaRMPHReitsmaFRRosendaalVandenbrouckeJP.Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74(1):449–53.
9.
PoortSRRLandolfiBertinaRM.Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency. Thromb Haemost 1997; 77(4):610–5.
10.
VandenbrouckeJPTKosterEBrietPHReitsmaRMBertinaRosendaalFR.Increased risk of venous thrombosis in oral contraceptive users who are carriers of Factor V Leiden mutation. Lancet 1994; 344(8935):1453–7.
11.
Rosendaal FR,Vessey M, Rumley A Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 2002; 116(4):851–4.
12.
WuOLRobertsonLanghorneP Oral contraceptives, hormone replacement therapy, thrombophilias and venous thromboembolism: a systematic review. The Thrombosis: Risk Economic Assessment of Thrombophilia Screening (TREATS) study. Thromb Haemost 2005; 94(1):17–25.
13.
BaglinTRLuddingtonKBrownBaglinC. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362(9383):523–6.
14.
VossenCYJConardFontcubertaJ Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect.The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 2005; 3(3):459–64.
15.
VossenCYJConradFontcubertaJ Familial thrombophila and lifetime risk of venous thrombosis. J Thromb Haemost 2004; 2(9):1526–32.
16.
MussetDFParentMeyerG Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360(9349):1914–20.
17.
WellsPSDRAndersonRodgerM Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED dimmer. Thromb Haemost 2000; 83(3):416–20.
18.
KruipMJMJSlobJHSchijenvan der HeulCBullerHR.Use of a clinical decision rule in combination with D-dimer concentrations in the diagnostic work up of patients with suspected pulmonary embolism: a prospective management study. Arch Intern Med 2002; 162(14):1631–5.
19.
SteinPDSEFowlerGoodmanLR Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354(22):2317–27.
20.
PerrierAPMRoySanchezO Multidetector-row computed tomography in suspected pulmonary embolism. N Eng J Med 2005; 352(17):1760–8.
21.
Van BelleAHRBullerHuismanMV Effectiveness of managing suspected pulmonary embolism using an algorithim combining clinical probability, D-dimer testing and computed tomography. JAMA 2006; 295(2):172–9.
22.
GabyERTaralaWillR Interstitial lung disease in recent onset rheumatoid arthritis. Am J Resp Crit Care Med 1997; 156(2 Pt 1):528–35.
ImokawaSTVColbyKOLeslieHelmersRA.Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Resp J 2000; 15(2):373–81.
25.
HalmEAPMoraNo symptomsLeventhal H., no asthma: the acute episodic disease belief is associated with poor self management among inner-city adults with persistent asthma. Chest 2006; 129(3):573–80
26.
HaughneyJGBarnesMPartridgeClelandJ. The Living &Breathing Study: a study of patients’ views of asthma and treatment. Prim Care Resprr J 2004; 13(1):28–35
27.
CaressALKBeaverKLukerMCampbellWoodcockA. Invovlement with treatment decisions: what do adults with asthma want and what do they get? Results of a cross sectional survey. Thorax 2005; 60(3):199–205.
28.
OsmanLMCCalderGoddenDJ A randomized trial of self management planning for adult patients admitted to hospital with acute asthma. Thorax 2002; 57(10):869–74.
29.
ShekelleP.New contract for general practitioners. BMJ 2003; 326(7387):457–8.
30.
RolandM.Linking physicians’ pay to the quality of care – a major experiment in the United Kingdom. N Engl J Med 2004; 351(14):1448–54.
31.
JatakanonASLimBarnesPJ.Changes in sputum eosinophils predict loss of asthma control. Am J Resp Crit Care Med 2000; 161(1):64–72.
32.
LeuppiJDCMSalomeJenkinsCR Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Resp Crit Care Med 2001; 163(2):406–12.
33.
GreenRHCEBrightlingMcKennaS Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360(9347):1715–21.
34.
JayaramLMMPizzichiniCookRJ Determining asthma treatment by monitoring sputum cell counts: effect in acute exacerbations. Eur Resp J 2006; 27(3):483–94.
HumbertMRBeasleyAyresJ Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy: INNOVATE. Allergy 2005; 60(3):309–16.
37.
HowarthPHKSBabuArshadHS Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005; 60(12):1012–8.
38.
CoxGJDMillerAMcWilliamsJMFitzgeraldLamS. Bronchial thermoplasty for asthma. Am J Resp Crit Care Med 2006; 173(9):965–9.
39.
CoxPGJMillerWMitznerLeffAR.Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations. Eur Resp J 2004; 24(4):659–63.
